HIV-related neurocognitive impairment in the HAART era. (Q37546230)

20 August 2017

1 reference

title

HIV-related neurocognitive impairment in the HAART era. (English)

1 reference

20 August 2017

0 references

Jessica Robinson-Papp

series ordinal

1

1 reference

20 August 2017

Kathryn J Elliott

series ordinal

2

1 reference

20 August 2017

David M Simpson

series ordinal

3

1 reference

20 August 2017

publication date

1 August 2009

1 reference

20 August 2017

published in

Current HIV/AIDS reports

1 reference

20 August 2017

volume

6

1 reference

20 August 2017

issue

3

1 reference

20 August 2017

page(s)

146-152

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-009-0020-1

20 August 2017

exact match

0 references

cites work

The AIDS dementia complex

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Cytomegalovirus encephalitis in acquired immunodeficiency syndrome (AIDS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

HIV Dementia Scale and psychomotor slowing--the best methods in screening for neuro-AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Abnormal brain activation on functional MRI in cognitively asymptomatic HIV patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Combination antiretroviral therapy improves psychomotor speed performance in HIV-seropositive homosexual men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-009-0020-1

Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort

21 January 2018

1 reference

12 December 2020

The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex

1 reference

12 December 2020

The HIV Dementia Scale: predictive power in mild dementia and HAART

1 reference

12 December 2020

Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1.

1 reference

12 December 2020

Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study.

1 reference

12 December 2020

Elevated cerebrospinal fluid quinolinic acid levels are associated with region-specific cerebral volume loss in HIV infection

1 reference

12 December 2020

Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy

1 reference

12 December 2020

Predictive validity of demographically adjusted normative standards for the HIV Dementia Scale

1 reference

12 December 2020

The International HIV Dementia Scale: a new rapid screening test for HIV dementia

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Initial validation of a screening battery for the detection of HIV-associated cognitive impairment

1 reference

12 December 2020

Safety and tolerability of the antioxidant OPC-14117 in HIV-associated cognitive impairment. The Dana Consortium on the Therapy of HIV Dementia and Related Cognitive Disorders

1 reference

12 December 2020

Cerebrospinal fluid beta 2-microglobulin in patients with AIDS dementia complex: an expanded series including response to zidovudine treatment

1 reference

12 December 2020

The aging HIV/AIDS population: fragile social networks

1 reference

12 December 2020

Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain

1 reference

12 December 2020

Assessment of AIDS-related cognitive changes: recommendations of the NIMH Workshop on Neuropsychological Assessment Approaches

1 reference

12 December 2020

A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment.

1 reference

12 December 2020

Atypical antipsychotic drugs and the risk of sudden cardiac death

1 reference

12 December 2020

Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers

1 reference

12 December 2020

Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force

1 reference

12 December 2020

HIV Dementia Scale: a rapid screening test.

1 reference

12 December 2020

Biomarkers of HIV-1 CNS infection and injury

1 reference

12 December 2020

The AIDS dementia complex: I. Clinical features

1 reference

12 December 2020

Valproic acid adjunctive therapy for HIV-associated cognitive impairment: a first report.

1 reference

12 December 2020

Enhancing antiretroviral therapy for human immunodeficiency virus cognitive disorders

1 reference

12 December 2020

Plan ahead: How neurologists can enhance patient-centered medicine

1 reference

12 December 2020

Central nervous system correlates of behavioral deficits following simian immunodeficiency virus infection

1 reference

12 December 2020

Neurological complications of acquired immune deficiency syndrome: Analysis of 50 patients

1 reference

12 December 2020

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment

1 reference

12 December 2020

The AIDS dementia complex: II. Neuropathology.

1 reference

12 December 2020

Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia.

1 reference

12 December 2020

A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment

1 reference

12 December 2020

Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage

1 reference

12 December 2020

Cognitive and motor impairments associated with SIV infection in rhesus monkeys.

1 reference

12 December 2020

Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study.

1 reference

12 December 2020

Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy.

1 reference

12 December 2020

Updated research nosology for HIV-associated neurocognitive disorders

1 reference

12 December 2020

10.1007/S11904-009-0020-1

Identifiers

DOI

1 reference

20 August 2017

1 reference